Mark B. Benjamin
Presidente presso Cyrus Biotechnology, Inc.
Profilo
Mark B.
Benjamin is currently the President & Executive VP-Business Development at Cyrus Biotechnology, Inc. Previously, he worked as a Senior Business Development Executive at Rosetta Inpharmatics LLC from 1999 to 2001.
He also served as the Chief Business Officer at Nura, Inc. Additionally, he was a Trustee at Seattle Biomedical Research Institute.
Dr. Benjamin holds a doctorate degree from Harvard University and an undergraduate degree from the University of London.
Posizioni attive di Mark B. Benjamin
Società | Posizione | Inizio |
---|---|---|
Cyrus Biotechnology, Inc.
Cyrus Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Cyrus Biotechnology, Inc. develops protein structure prediction and protein design software. The company was founded by Lucas Nivon, David Baker, Javier Castellanos and Yifan Song and is headquartered in Seattle, WA | Presidente | - |
Precedenti posizioni note di Mark B. Benjamin
Società | Posizione | Fine |
---|---|---|
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Corporate Officer/Principal | 01/01/2001 |
Seattle Biomedical Research Institute
Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Direttore/Membro del Consiglio | - |
Nura, Inc.
Nura, Inc. Pharmaceuticals: MajorHealth Technology Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formazione di Mark B. Benjamin
University of London | Undergraduate Degree |
Harvard University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Nura, Inc.
Nura, Inc. Pharmaceuticals: MajorHealth Technology Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA. | Health Technology |
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
Seattle Biomedical Research Institute
Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |
Cyrus Biotechnology, Inc.
Cyrus Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Cyrus Biotechnology, Inc. develops protein structure prediction and protein design software. The company was founded by Lucas Nivon, David Baker, Javier Castellanos and Yifan Song and is headquartered in Seattle, WA | Commercial Services |
- Borsa valori
- Insiders
- Mark B. Benjamin